Grupo de Investigación:
SISTEMES NANOSTRUCTURATS D'ALLIBERAMENT CONTROLAT DE FÀRMACS
Grup d'Innovació Docent en Anàlisi Instrumental Farmacèutic
Información de contacto
Rectorado
Av. Joan XXIII, 27-31 696793679 esanchezlopez(a)ub.edu
Formación académica
Pharmacy
Master in Research, Development and Drug Control
Animal experimentation course
Experimental Master in Pharmaceutical Sciences
Lineas de investigación
Development of Polymeric nanoparticles for Alzheimer's diseaseDevelopment,characteritzation and in vivo efficacy assesment of polymeric nanoparticles for glaucomaDevelopment of protein liposomes for ocular drug deliveryDevelopment of polymeric nanoparticles encapsulating nonsteroidal anti-inflammatory drugs for ocular drug deliveryEvaluation of cytotoxicity and cellular uptake of nanostrutured systems for controlled drug deliveryFreeze dry of pharmaceutical formulations
Proyectos
Sistemes nanoestructurats d'alliberament controlat de fàrmacs
.
2014 - 2017
. Ref.2014SGR1023
. Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR)
. IP: Maria Luisa Garcia LopezAnalysis of the stress mechnisms during sterilization and stabilization by lyophilisation of nanostructured biomaterials and the effects on their biopharmaceutical profiles
.
2012 - 2014
. Ref.MAT2011-26994
. Ministerio de Ciencia e Innovación (MICINN)
. IP: Maria Luisa Garcia LópezSIIN2Brain: safe implementation of innovative nanomedicines for Alzheimer's disease
.
2015 - 2015
. Ref.Ayudas UB Horitzon 2020
. Vicerectorat de Recerca, Innovació i Transferència
. IP: Maria Luisa Garcia LópezAplicación de criterios de calidad basada en el diseño al proceso de liofilización de sistemas nanoestructurados para el tratamiento de enfermedades neurodegenerativas
.
2015 - 2017
. Ref.MAT2014-59134-R
. Ministerio de Ciencia e Innovación (MICINN)
. IP: Maria Luisa Garcia LopezColloidal systems for ocular drug delivery
.
2017 - 2017
. Ref.309246
. Terra di Cuma
. IP: Maria Luisa Garcia LopezColloidal system for ocular drug delivery
.
2017 - 2017
. Ref.309246
. Terra di Cuma
. IP: Maria Luisa Garcia LopezDesign of an age-dependent corneal membrane model for in vitro interaction studies of biodegradable polymeric nanoparticles. In vitro/ex vivo/in vivo correlation
.
2018 - 2019
. Ref.24345
. Institut de Nanociència i Nanotecnologia de la UB. IN2UB.
. IP: Elena Sanchez LopezTiquets d'innovació UB. Viabilitat i caracterització fisicoquímica de sistemes nanoestructurats per administració oral i tòpica
.
2020 - 2021
. Technology dedicated to care España, S.L.
. IP: Maria Luisa García i Elena Sánchez López
Publicaciones relevantes
Sánchez-López, E.; Ettcheto, M.; Egea, M.A.; Espina, M.; Calpena, A.C.; Folch, J.; Camins, A.; García, M.L. New Potential Strategies for Alzheimer's Disease Prevention: Pegylated biodegradable Dexibuprofen nanospheres administration to APPswe/PS1dE9.
En
Nanomedicine: Nanotechnology, Biology and Medicine.
Volumen 2017.
Número 13.
2017
. https://doi.org/10.1016/j.nano.2016.12.003Ettcheto M.; Sánchez-López E.; Pons L.; Busquets O.; Olloquequi J.; Beas-Zarate C.; Pallas M.; García M.L.; Auladell C.; Folch J.; Camins A. Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways.
En
Redox Biology.
Volumen 13.
2017
. Repositorio InstitucionalSánchez-López, E.; Cano, A.; Ettcheto, M.; Egea, M.A.; Espina, M.; Calpena, A.C.; Folch, J.; Camins,A.; García, M.L. Dexibuprofen loaded PEGylated nanospheres for Alzheimer's disease treatment.
En
Journal of Controlled Release.
Número 259.
2017
. https://doi.org/10.1016/j.jconrel.2017.03.086Sánchez-López, E.; Egea, M.A; Davis, B.M.; Guo, L.; Espina, M.; Silva,A.M.; Calpena,A.C.; Souto,E.B.; Ravindran, N.; Ettcheto, M.; Camins, A.; García, M.L.; Cordeiro, M.F. Memantine loaded PEGylated biodegradable nanoparticles for the treatment of glaucoma.
En
Small.
2018
. https://doi.org/10.1002/smll.201701808Sánchez-López, E.: Espina, M.; Doktorovova, S.; Souto, E.B.; García, M.L. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II Ocular drug loaded lípid nanoparticles.
En
European Journal of Pharmaceutics and Biopharmaceutics.
Volumen 110.
2017
. https://doi.org/10.1016/j.ejpb.2016.10.013Sánchez-López, E.; Espina, M.; Doktorovova, S.; Souto, E.B.; García, M.L. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery.
En
European Journal of Pharmaceutics and Biopharmaceutics.
Volumen 100.
2017
. https://doi.org/10.1016/j.ejpb.2016.10.009Cano, A.; Sánchez-López, E.; Espina, M.; Egea, M.A.; García, M.L. Polymeric nanoparticles of (-)-epigallocatechin gallate: A new formulation for the treatment of ocular diseases.
En
Journal of Controlled Release.
Volumen 259.
2017
. https://doi.org/10.1016/j.jconrel.2017.03.046Sánchez-López,E.; Egea, M.A.; Cano, A.; Espina, M.; Calpena, A.C.; Ettcheto, M.; Camins, A.; Souto, E.B.; Silva, A.M.; García, M.L. PEGylated PLGA naospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization.
En
Colloids and Surfaces B-Biointerfaces.
Volumen 145.
2016
. Repositorio InstitucionalSánchez-López, E.; Ettcheto, M.; Egea, M.A; Espina, M.; Cano, A; Calpena,A.C.; Camins, A.; Carmona, N.; Silva,A.M.; Souto,E.B.; García, M.L. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
En
Journal of Nanobiotechnology.
Volumen 16.
Número 32.
2018
. Repositorio InstitucionalElena Sánchez-López; Anna Paús; Ignacio Pérez-Pomeda; Ana Calpena;Isabel Haro and María José Gómara. Lipid Vesicles Loaded with an HIV-1 Fusion Inhibitor Peptide as a Potential Microbicide.
En
Pharmaceutics.
Volumen 12.
Número 6.
2020
. Repositorio Institucional
Patentes, Software y Bases de datos
Liposomes for the treatment of ocular pathologies (EP 3603621 A1 i US 10,835,494 B2) (ITALIA, 31/07/2018)
Composition comprising nanoparticles, method for the preparation of a composition comprising nanoparticles and uses of the composition for dental treatment (---, 12/06/2020)